This inventor holds 1 USPTO granted patent. Top assignee: Immunotech. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: The Innovations of David Jarrossay
Introduction
David Jarrossay is a notable inventor based in Marseilles, France. He has made significant contributions to the field of biochemistry, particularly in the area of erythrocyte lysis. His innovative approach has led to the development of a unique method that enhances the efficiency of blood analysis.
Latest Patents
David Jarrossay holds a patent for "Reagents and a method for the lysis of erythrocytes." This patent describes a process where whole blood, treated with an anticoagulant, is subjected to a pH range between 4 and 9. The method utilizes a nitrogenous heterocyclic compound, with pyrrolidine chloride being the preferred choice. This innovation is crucial for improving laboratory procedures involving blood samples.
Career Highlights
Throughout his career, David has worked with Immunotech, a company known for its advancements in immunology and biochemistry. His role at Immunotech has allowed him to collaborate with other experts in the field, further enhancing his contributions to scientific research.
Collaborations
One of his notable coworkers is Andre Van Agthoven. Their collaboration has fostered a productive environment for innovation and research within Immunotech.
Conclusion
David Jarrossay's work exemplifies the impact of innovative thinking in the field of biochemistry. His patent for erythrocyte lysis represents a significant advancement that can benefit various medical and research applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile